Legend: 
= Applied Session,
= Theme Session,
= Presenter, Sheraton Seattle Hotel & Towers = “S”
Washington State Convention & Trade Center = “CC”, Grand Hyatt Seattle = “H”
|
|
|
|
|
548
|
Thu, 8/10/06, 10:30 AM - 12:20 PM
|
CC-610
|
|
Step Up, Step Down Multiple Comparisons - Contributed - Papers
|
Biopharmaceutical Section
|
|
Chair(s): Mary J. Bartholomew, U.S. Food and Drug Administration
|
|
10:35 AM
|
A Non-Bonferroni Step-Up Rejection Procedure —  Jianjun Li, Merck Research Laboratories
|
|
10:50 AM
|
Gatekeeping Procedures for Dose-Finding Problems with Multiple Endpoints — Xin Wang, Northwestern University
|
|
11:05 AM
|
Comparison of Two Step-Down Linear Trend Tests — Kaifeng Lu, Merck & Co., Inc.
|
|
11:20 AM
|
A New Gatekeeping Strategy for Hierarchical-Structured Hypotheses in Clinical Trials — Junyuan Wang, The Medicines Company; Yan Zheng, University of Minnesota; Guanghan Liu, Merck Research Laboratories
|
|
11:35 AM
|
Hochberg's Step-Up Method: Cutting Corners off Holm's Step-Down Method — Yifan Huang, H. Lee Moffitt Cancer Center & Research Institute; Jason Hsu, The Ohio State University
|
|
11:50 AM
|
Testing the Assumption in Several Amalagamation-Based Tests for Dose Response — Arthur Roth, Pfizer Inc.
|
|
12:05 PM
|
Exploring Dose Response in Flexible-Dose Clinical Trials Using Marginal Structural Models: a Clinical Trial Example — Ilya Lipkovich, Eli Lilly and Company; Craig Mallinckrodt, Eli Lilly and Company; Douglas Faries, Eli Lilly and Company
|
| |
